Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
OCD: early-phase trial registry
13 of 19 indexed OCD trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 13 currently recruiting · #902 of 28,707 conditions by registered trial count
OCD: 19 US clinical trials tracked, 13 recruiting.
OCD is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 2 of these trials.
Enrollment posture brief
Registry condition ocd
OPEN 13 | RECR 68% | LATE 0 | EARLY 4 | RANK #902 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Gestational Hypertension (68% recruiting · 19 trials)
OCD lists 13 open slots (68% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for OCD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
OCD is recruiting above its size-band peers.
13 of 19 indexed trials (68.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of OCD trials is spread across many organizations.
Yale University accounts for 2 of 19 trials (10.5%). 17 distinct sponsors appear on at least one study for this condition label.
-
Typical OCD enrolment sits around 84 participants.
Median target enrolment is 84 among the 19 trials that report a genuine target (sentinel values excluded). 11 of those (57.9%) plan for fewer than 100 participants.
-
OCD research is mostly interventional.
14 interventional and 5 observational studies make up this index (73.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Neuronetics
NCT06997549
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
Bradley Hospital
NCT06934525
Discovering Factors in the Clinical Study Journey of Patients With OCD
Power Life Sciences
NCT05881356
Accelerated TMS for Depression and OCD
Weill Medical College of Cornell University
NCT04982757
Neurostimulation Versus Therapy for Problems With Emotions
Duke University
NCT05712057
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
NCT06624137
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
University of Pennsylvania
NCT05359562
Neuromodulation for a Novel OCD Biomarker and Treatment
Boston University Charles River Campus
NCT05994053
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
Han Joo Lee
NCT06731426
Paired tVNS With ERP in OCD
University of Florida
NCT05580614
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
NCT06442423
Light Therapy for Obsessive-compulsive Disorder (OCD)
Washington University School of Medicine
NCT06720090
Personalized DBS for OCD Guided by Stereoencephalography Mapping
Andrew Moses Lee, MD, PhD
NCT06347978
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
Stanford University
NCT03511534
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
University of Chicago
NCT05624528
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
Baylor College of Medicine
NCT03459456
Testing a Transdiagnostic TMS Treatment Target
Brigham and Women's Hospital
NCT06282146
Development of an Instrument That Monitors Behaviors Associated With OCD
University of Minnesota
NCT02866422
Rapid Non-Invasive Brain Stimulation for OCD (oTMS)
Stanford University
NCT03404609
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on OCD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on OCD trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this OCD page
19 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 OCD trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Yale University sponsors the most OCD trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This OCD condition card totals 19 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.